JUL 01, 2021 8:00 AM PDT

Quality control advancements in therapeutic genome editing and biomanufacturing

Sponsored by: Genomic Vision
Speaker

Abstract
Date:  July 1, 2021
Time: 8:00am (PDT),  11:00am (EDT),  5:00pm (CEST)
 
What’s driving precision-medicine innovations? New advances in gene and cell therapy manufacturing, along with more elegant genome editing tools.
 
And what’s the biggest challenge? Deriving consistent, safe gene and cell therapy products is a major hurdle, as the process has the potential for unintended modifications that could hamper full translation into the clinic.
 
Get a first look at the Genomic Vision Quality Control Assay (QCA) for therapeutic genome editing and biomanufacturing. This state-of-the-art assay provides direct visualization of non-amplified single DNA molecules, enabling digital quantification of gene editing outcomes, including transgene copy numbers and integration patterns.
 
In this talk, you’ll discover how to use QCA to:
  1. Quantify the efficiency and fidelity of gene editing therapies to deliver safe therapies to clinicians.
  2. Characterize transgene integration patterns with high sensitivity and quantitative results to precisely monitor the quality of cell lines
You can then assess their stability throughout the manufacturing process: an essential step in the developing and producing biologics.

 

Learning Objectives:
  • Summarize how molecular combing can be used to ensure consistent, safe gene and cell therapy products
  • Learn how the Genomic Vision Quality Control Assay (QCA) can be an effective tool in therapeutic genome editing and biomanufacturing

 

 

 
 
 
  • July 1 - Quality control advancements in therapeutic genome editing and biomanufacturing - Dr. Imen Mestiri
    • Therapeutic genome editing, Biomanufacturing
 
Webinars will be available for unlimited on-demand viewing after live event.

Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
JUN 24, 2021 10:00 AM PDT
C.E. CREDITS
JUN 24, 2021 10:00 AM PDT
Date: June 24, 2021 Time: 10:00am PDT The Chan Zuckerberg Initiative (CZI) was founded to help solve some of society’s toughest challenges— from eradicating disease and improving...
Loading Comments...
Show Resources